November 28, 2017 at 4:10 p.m. | Print view
A company based in Des Moines will be the first in Iowa licensed to grow cannabis and manufacture medical products from it.
The Iowa Department of Public Health intends to grant a cannabidiol manufacturing license to MedPharm Iowa, the company announced on Tuesday. MedPharm Iowa is a company owned by Chris Nelson, president and CEO of Kemin Industries.
A spokeswoman for the state department confirmed that it had issued the notice, but said the department has until December 1 to formally provide the license.
In a press release, Nelson said that "botanists, including the cannabis plant, offer endless possibilities."
"With the creation of MedPharm Iowa, we will use our innovative experience and experience with scientifically sound research to help those with chronic pain, cancer, debilitating diseases and possible help to alleviate the opioid epidemic in Iowa," said Nelson.
Under the license, MedPharm Iowa will grow cannabis and manufacture medicinal cannabidiol at a facility located on the Des Moines campus in Kemin. MedPharm needs to begin supplying medical cannabidiol before December 1, 2018, it said in the statement.
In May, then-Gov. Terry Branstad signed a law that expanded Iowa's medical cannabis program. The legislation allowed two licensed medical cannabis manufacturers licensed by the state to receive licenses.
It also expanded what patients could use medicinal cannabis to treat cancer, multiple sclerosis, AIDS or HIV and other diseases.
l Comments: (319) 398-8366; [email protected]
Do you like what you are reading?
We make it easy to stay connected:
Subscribe to our newsletters by email
Download our free applications